However, tissue and cancer-grade specific effects might be observed, as a recently published study revealed that ZBTB7A was commonly deleted in late stage oesophageal, bladder, colorectal, lung, ovarian and uterine cancers (Liu et al., 2014). This evidence concerns the gene ZBTB7A and cancer.